Publicaciones en colaboración con investigadores/as de University of Washington (20)

2023

  1. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

2021

  1. Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2709-2718

  2. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

  3. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

2019

  1. Humoral response to natural influenza infection in solid organ transplant recipients

    American Journal of Transplantation, Vol. 19, Núm. 8, pp. 2318-2328

2018

  1. A 5-year prospective multicenter evaluation of influenza infection in transplant recipients

    Clinical Infectious Diseases, Vol. 67, Núm. 9, pp. 1322-1329

2010

  1. Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis

    Transplantation, Vol. 89, Núm. 1, pp. 69-74

  2. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients

    Clinical Infectious Diseases, Vol. 51, Núm. 9, pp. 1062-1069

2009

  1. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated

    Bone Marrow Transplantation, Vol. 44, Núm. 8, pp. 495-507

  2. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis

    Clinical Infectious Diseases, Vol. 49, Núm. 11, pp. 1721-1728

  3. Safe living after hematopoietic cell transplantation

    Bone Marrow Transplantation, Vol. 44, Núm. 8, pp. 509-519

2008

  1. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis

    Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 2, pp. 735-738

  2. Central nervous system cryptococcosis in solid organ transplant recipients: Clinical relevance of abnormal neuroimaging findings

    Transplantation, Vol. 86, Núm. 5, pp. 647-651

  3. Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen

    Clinical Infectious Diseases, Vol. 46, Núm. 2

2007

  1. Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality

    Journal of Infectious Diseases, Vol. 195, Núm. 5, pp. 756-764

2006

  1. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study

    Transplantation, Vol. 81, Núm. 3, pp. 320-326

  2. Late-onset invasive aspergillosis in organ transplant recipients in the current era

    Medical Mycology, Vol. 44, Núm. 5, pp. 445-449

2005

  1. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome

    Transplantation, Vol. 80, Núm. 8, pp. 1131-1133

  2. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients

    Clinical Infectious Diseases, Vol. 40, Núm. 12, pp. 1756-1761

  3. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection

    Transplantation, Vol. 80, Núm. 8, pp. 1033-1039